Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Episode | Date |
---|---|
Topical BRAF-inhibiting Gel Controls Acneiform Rash in Patients with Colorectal Cancer Treated with EGFR-inhibition
|
May 02, 2025 |
Adding Perioperative Pembrolizumab to Standard of Care Improves Outcomes in Patients with Newly Diagnosed Head and Neck Cancers
|
May 01, 2025 |
RAS Inhibitor Zoldonrasib Brings Clinical Benefit in Patients with G12D Mutated Non-Small Cell Advanced Lung Cancer
|
Apr 30, 2025 |
Exosome Liquid Biopsy for Earliest Pancreatic Cancer Detection
|
Apr 10, 2025 |
Long Remissions with Bispecific T-cell Engager Antibody Therapy for Patients with Relapsed Multiple Myeloma
|
Apr 09, 2025 |
Personalized Vaccine Brought Durable Immune Responses and Fewer Relapses in Head and Neck Cancers
|
Apr 09, 2025 |
Adding Anthracycline Improved Outcomes for Patients with High-Risk HR-positive, HER2-negative Breast Cancer
|
Mar 28, 2025 |
Specific Subgroups of Patients with Metastatic Castration Resistant Prostate Cancer Live Longer with Talazoparib Added to their Enzalutamide Therapy
|
Mar 13, 2025 |
Patients with Desmoplastic Melanoma Were Exceptional Responders to Single Agent Pembrolizumab
|
Mar 11, 2025 |
Bilateral Mastectomy and Salpingo-Oophorectomy Significantly Extend Survival In BRCA-mutation Carriers Who Already Have Breast Cancer
|
Feb 26, 2025 |
AUDIO JOURNAL OF ONCOLOGY: Randomized Study Found Surgery-Sparing Active Monitoring Safe in Patients With Low-risk DCIS
|
Jan 16, 2025 |
AUDIO JOURNAL OF ONCOLOGY: Safe to Spare Post-Mastectomy Chest Wall Radiotherapy in Most Patients with Intermediate Risk Breast Cancer
|
Jan 11, 2025 |
AUDIO JOURNAL OF ONCOLOGY: Increased Dietary Fiber Brings Longer Survival and Less GVHD After Allogeneic Stem Cell Transplantation
|
Jan 08, 2025 |
Adding a Bi-Specific T-Cell Engager Brings Striking Benefit in Childhood Acute Lymphoblastic Leukemia
|
Dec 17, 2024 |
Double-Edged CAR-T Therapy Improves Survival with Relapsed/Refractory Chronic Lymphoblastic Leukemia
|
Dec 09, 2024 |
Low Rates of Early Detection Drive Excess Breast Cancer Mortality in Underserved Communities
|
Apr 26, 2023 |
AUDIO JOURNAL OF ONCOLOGY—Options Identified for Chemotherapy Intensity Reduction in Acute Lymphoblastic Leukemia
|
Feb 13, 2023 |
AUDIO JOURNAL OF ONCOLOGY—Don’t Delay Stem Cell Transplant For Patients with Relapsed or Refractory Acute Myeloid Leukemia
|
Jan 23, 2023 |
AUDIO JOURNAL OF ONCOLOGY—Ibrutinib Enables Transplant-Free Therapy for Mantle Cell Lymphoma
|
Jan 20, 2023 |
AUDIO JOURNAL OF ONCOLOGY—Fast Durable Responses to Bi-Specific Antibody Therapy In Heavily Pre-Treated Multiple Myeloma
|
Jan 09, 2023 |
AUDIO JOURNAL OF ONCOLOGY—High Response Rates in Lung Cancer from Next Generation ROS1 Inhibitor
|
Jan 06, 2023 |
AUDIO JOURNAL OF ONCOLOGY – ARROS-1 Study Finds ROS1 Tyrosine Kinase Inhibitor Has Promise as a Tumor Agnostic Therapy
|
Jan 05, 2023 |
AUDIO JOURNAL OF ONCOLOGY—Pan-AKT Inhibitor Tumor Agnostic Targeting was Safe and Effective in Phase One Study
|
Jan 04, 2023 |
AUDIO JOURNAL OF ONCOLOGY—MYC-Targeted Drug Had Excellent Safety And Solid Tumor Responses
|
Dec 02, 2022 |
AUDIO JOURNAL OF ONCOLOGY—New Molecular Drug has Clinical Activity in Hepatocellular Carcinoma
|
Nov 11, 2022 |
AUDIO JOURNAL OF ONCOLOGY—Cell Therapy Markedly Improved Outcomes After Immunotherapy in Melanoma
|
Nov 08, 2022 |
AUDIO JOURNAL OF ONCOLOGY—Glioma in Adults: Next Generation Sequencing Validates BRAF Targeting
|
Nov 07, 2022 |
AUDIO JOURNAL OF ONCOLOGY—First Line Atezolizumab Extends Life in Unfit Patients with Lung Cancer
|
Oct 22, 2022 |
AUDIO JOURNAL OF ONCOLOGY—Breast Conservation: Machine-Learning Helps De-Escalate Breast Cancer Therapy
|
Oct 14, 2022 |
AUDIO JOURNAL OF ONCOLOGY—PARP-Inhibition Beyond Initial Therapy Extends Life with Advanced Ovarian Cancer
|
Oct 11, 2022 |
AUDIO JOURNAL OF ONCOLOGY – ”Progression to Acute Myeloid Leukemia Explained by Multi Omics Analysis
|
Oct 10, 2022 |
AUDIO JOURNAL OF ONCOLOGY—“PM 2.5” Evidence Links Particulate Air Pollution to Non-Small Cell Lung Cancer
|
Oct 03, 2022 |
CT Screening Cuts Lung Cancer Deaths 24-Per Cent Second Study Confirms
|
Feb 24, 2020 |
Volume CT Lung Cancer Screening Cuts Cancer Deaths 24 Per Cent
|
Feb 07, 2020 |
New Front Line Standard for Older Patients with Chronic Lymphocytic Leukemia
|
Jan 24, 2020 |
Microbiome Diversity Key To Survival After Allogeneic Hematopoietic Cell Transplantation
|
Jan 14, 2020 |
Genomic-led AML Clinical Decision Making Within Seven Days
|
Dec 31, 2019 |
Ibrutinib: New Frontline Standard for Chronic Lymphocytic Leukemia?
|
Oct 07, 2019 |
Ibrutinib: New Frontline Standard for Chronic Lymphocytic Leukemia?
|
Oct 07, 2019 |
Head and Neck Cancer Therapy De-Escalation: A “Salutary Lesson”
|
Nov 12, 2018 |
Which New Combination for Metastatic Renal Cell Cancer?
|
Nov 12, 2018 |
Two Drug Combination Doubled Kidney Cancer Progression Free Survival
|
Nov 07, 2018 |
ALK—Targeted Lung Cancer Drugs Benefited Real World Patients
|
Nov 07, 2018 |
First Line PARP Inhibition For Ovarian Cancer Assessed
|
Nov 02, 2018 |
BRCA1/2 Ovarian Cancer—Three Years Disease Free with First-Line Olaparib
|
Nov 01, 2018 |
PD-L1 Immunotherapy Delayed Triple Negative Breast Cancer Progression
|
Oct 31, 2018 |
Genomically Targeted Therapy Delays Advanced Breast Cancer Progression
|
Oct 31, 2018 |
Palbociclib Combination Prolongs Life After Breast Cancer Hormone Therapy
|
Oct 29, 2018 |
Long Overall Survival in Ceritinib-Treated ALK-Positive Lung Cancer
|
Oct 27, 2018 |
Pembrolizumab: No Survival Gains Second Line In Gastric Cancer
|
Oct 18, 2018 |